We Provide Smart Consultancy to Manage EAPs Easier

EAPs are complicated. They are affected by numerous variables – not just regulatory jurisdictions, but also how they link to asset development and commercialization plans.

Our consultancy team can help you decide if an EAP is right for your asset, find the optimal timing, understand the regulatory structure, and integrate your EAP with RWD and commercialisation.

Our consultancy team brings together experience in pharmaceutical commercialization, international regulatory law, and pharmacy – domestically and internationally. We’ll work with you to develop the best solution for each potential therapy.

Team experienced in

Physicians want to do the best for their patients and often ask for access to innovative new therapies.

Team experienced in

Launch marketing
International pharmaceutical law
GxP regulations and implementation
International pharmacy
Pharmaceutical development
Health economics
Physician and HCP training and engagement
Patient and charity engagement

Typical projects

Typically, our team works with functions across your pharma biotech company, providing insight into:

Whether an EAP is right for your therapy/company

Integration into further development including real world data collection

Feasibility studies by country, region and globally

Preparation of business cases

Development of EAP policies